Global Seasickness Medicine Market
Global Seasickness Medicine Market

Seasickness Medicine Comprehensive Study by Type (Anticholinergic, Antihistamines), Route of Administration (Oral, Transdermal, Parenteral, Other), Distribution Channel (Retail Pharmacies, Online Pharmacies, Others) Players and Region - Global Market Outlook to 2026

Seasickness Medicine Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Jun 2021 Edition 222 Pages 217 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
The Global Seasickness Medicine market presents a comprehensive analysis of the Seasickness Medicine market by product type (Anticholinergic and Antihistamines), and by geography (North America, South America, Europe, Asia-Pacific and MEA) along with country level break-up.

Market Snapshot:
Seasickness is a common condition characterized by a set of symptoms such as dizziness, nausea, and fatigue experienced by a person while traveling. It is caused by differences in impulses received by the perceived sense of motion by visual senses and the vestibular systemís sense of movement. Various prescription and OTC drugs and products are used to treat Seasickness and provide relief from their symptoms. Anticholinergic, antihistamines, and sympathomimetic are the most commonly used medications.

Market Drivers
  • Increased Number of Travellers and Virtual Reality Exposure Across the Globe
  • Rising Adoption of Prescription Seasickness Medicine

Market Trend
  • Advent of Nauseogenic Information Technology

Restraints
  • Reluctance in Emerging Countries due to Higher Cost of Prescription Drugs
  • Excessive Reliance on the OTC and Traditional Medicines


Geographic Segmentation and Analysis
This section of our report presents a realistic picture of the Global Seasickness Medicine industry. Investors and manufacturers can easily understand the inherent opportunities and challenges for their products in geographical region of interest.
The regional segmentation covered in this report are:
South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)

Frequently Asked Questions (FAQ):

1. Why many important players are not profiled in the study?
Due to pricing constraints we only profile limited players in the study that includes a mix list of leaders and emerging players, however for evaluation of market size the coverage includes 100+ players.

2. How big is the Seasickness Medicine Market?
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2026

3. Is it possible to have certain customization in the study?
The Study can be customized to meet your requirements. Please connect with our representative, in case you wish to add or remove certain country or profiled players.
Report Objectives / Segmentation Covered
By Type
  • Anticholinergic
  • Antihistamines
By Route of Administration
  • Oral
  • Transdermal
  • Parenteral
  • Other

By Distribution Channel
  • Retail Pharmacies
  • Online Pharmacies
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Number of Travellers and Virtual Reality Exposure Across the Globe
      • 3.2.2. Rising Adoption of Prescription Seasickness Medicine
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Rules and Regulations
    • 3.4. Market Trends
      • 3.4.1. Advent of Nauseogenic Information Technology
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Seasickness Medicine, by Type, Route of Administration, Distribution Channel and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Seasickness Medicine (Value)
      • 5.2.1. Global Seasickness Medicine by: Type (Value)
        • 5.2.1.1. Anticholinergic
        • 5.2.1.2. Antihistamines
      • 5.2.2. Global Seasickness Medicine by: Route of Administration (Value)
        • 5.2.2.1. Oral
        • 5.2.2.2. Transdermal
        • 5.2.2.3. Parenteral
        • 5.2.2.4. Other
      • 5.2.3. Global Seasickness Medicine by: Distribution Channel (Value)
        • 5.2.3.1. Retail Pharmacies
        • 5.2.3.2. Online Pharmacies
        • 5.2.3.3. Others
      • 5.2.4. Global Seasickness Medicine Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Seasickness Medicine: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. GlaxoSmithKline plc (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Perrigo Company plc (Ireland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Prestige Brands (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. WellSpring Pharmaceutical Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Caleb Pharmaceuticals (Taiwan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Myungmoon Pharm Co. (South Korea)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Baxter International (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Reliefband Technologies LLC. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. CVS Health (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Seasickness Medicine Sale, by Type, Route of Administration, Distribution Channel and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Seasickness Medicine (Value)
      • 7.2.1. Global Seasickness Medicine by: Type (Value)
        • 7.2.1.1. Anticholinergic
        • 7.2.1.2. Antihistamines
      • 7.2.2. Global Seasickness Medicine by: Route of Administration (Value)
        • 7.2.2.1. Oral
        • 7.2.2.2. Transdermal
        • 7.2.2.3. Parenteral
        • 7.2.2.4. Other
      • 7.2.3. Global Seasickness Medicine by: Distribution Channel (Value)
        • 7.2.3.1. Retail Pharmacies
        • 7.2.3.2. Online Pharmacies
        • 7.2.3.3. Others
      • 7.2.4. Global Seasickness Medicine Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Seasickness Medicine: by Type(USD Million)
  • Table 2. Seasickness Medicine Anticholinergic , by Region USD Million (2015-2020)
  • Table 3. Seasickness Medicine Antihistamines , by Region USD Million (2015-2020)
  • Table 4. Seasickness Medicine: by Route of Administration(USD Million)
  • Table 5. Seasickness Medicine Oral , by Region USD Million (2015-2020)
  • Table 6. Seasickness Medicine Transdermal , by Region USD Million (2015-2020)
  • Table 7. Seasickness Medicine Parenteral , by Region USD Million (2015-2020)
  • Table 8. Seasickness Medicine Other , by Region USD Million (2015-2020)
  • Table 9. Seasickness Medicine: by Distribution Channel(USD Million)
  • Table 10. Seasickness Medicine Retail Pharmacies , by Region USD Million (2015-2020)
  • Table 11. Seasickness Medicine Online Pharmacies , by Region USD Million (2015-2020)
  • Table 12. Seasickness Medicine Others , by Region USD Million (2015-2020)
  • Table 13. South America Seasickness Medicine, by Country USD Million (2015-2020)
  • Table 14. South America Seasickness Medicine, by Type USD Million (2015-2020)
  • Table 15. South America Seasickness Medicine, by Route of Administration USD Million (2015-2020)
  • Table 16. South America Seasickness Medicine, by Distribution Channel USD Million (2015-2020)
  • Table 17. Brazil Seasickness Medicine, by Type USD Million (2015-2020)
  • Table 18. Brazil Seasickness Medicine, by Route of Administration USD Million (2015-2020)
  • Table 19. Brazil Seasickness Medicine, by Distribution Channel USD Million (2015-2020)
  • Table 20. Argentina Seasickness Medicine, by Type USD Million (2015-2020)
  • Table 21. Argentina Seasickness Medicine, by Route of Administration USD Million (2015-2020)
  • Table 22. Argentina Seasickness Medicine, by Distribution Channel USD Million (2015-2020)
  • Table 23. Rest of South America Seasickness Medicine, by Type USD Million (2015-2020)
  • Table 24. Rest of South America Seasickness Medicine, by Route of Administration USD Million (2015-2020)
  • Table 25. Rest of South America Seasickness Medicine, by Distribution Channel USD Million (2015-2020)
  • Table 26. Asia Pacific Seasickness Medicine, by Country USD Million (2015-2020)
  • Table 27. Asia Pacific Seasickness Medicine, by Type USD Million (2015-2020)
  • Table 28. Asia Pacific Seasickness Medicine, by Route of Administration USD Million (2015-2020)
  • Table 29. Asia Pacific Seasickness Medicine, by Distribution Channel USD Million (2015-2020)
  • Table 30. China Seasickness Medicine, by Type USD Million (2015-2020)
  • Table 31. China Seasickness Medicine, by Route of Administration USD Million (2015-2020)
  • Table 32. China Seasickness Medicine, by Distribution Channel USD Million (2015-2020)
  • Table 33. Japan Seasickness Medicine, by Type USD Million (2015-2020)
  • Table 34. Japan Seasickness Medicine, by Route of Administration USD Million (2015-2020)
  • Table 35. Japan Seasickness Medicine, by Distribution Channel USD Million (2015-2020)
  • Table 36. India Seasickness Medicine, by Type USD Million (2015-2020)
  • Table 37. India Seasickness Medicine, by Route of Administration USD Million (2015-2020)
  • Table 38. India Seasickness Medicine, by Distribution Channel USD Million (2015-2020)
  • Table 39. South Korea Seasickness Medicine, by Type USD Million (2015-2020)
  • Table 40. South Korea Seasickness Medicine, by Route of Administration USD Million (2015-2020)
  • Table 41. South Korea Seasickness Medicine, by Distribution Channel USD Million (2015-2020)
  • Table 42. Taiwan Seasickness Medicine, by Type USD Million (2015-2020)
  • Table 43. Taiwan Seasickness Medicine, by Route of Administration USD Million (2015-2020)
  • Table 44. Taiwan Seasickness Medicine, by Distribution Channel USD Million (2015-2020)
  • Table 45. Australia Seasickness Medicine, by Type USD Million (2015-2020)
  • Table 46. Australia Seasickness Medicine, by Route of Administration USD Million (2015-2020)
  • Table 47. Australia Seasickness Medicine, by Distribution Channel USD Million (2015-2020)
  • Table 48. Rest of Asia-Pacific Seasickness Medicine, by Type USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific Seasickness Medicine, by Route of Administration USD Million (2015-2020)
  • Table 50. Rest of Asia-Pacific Seasickness Medicine, by Distribution Channel USD Million (2015-2020)
  • Table 51. Europe Seasickness Medicine, by Country USD Million (2015-2020)
  • Table 52. Europe Seasickness Medicine, by Type USD Million (2015-2020)
  • Table 53. Europe Seasickness Medicine, by Route of Administration USD Million (2015-2020)
  • Table 54. Europe Seasickness Medicine, by Distribution Channel USD Million (2015-2020)
  • Table 55. Germany Seasickness Medicine, by Type USD Million (2015-2020)
  • Table 56. Germany Seasickness Medicine, by Route of Administration USD Million (2015-2020)
  • Table 57. Germany Seasickness Medicine, by Distribution Channel USD Million (2015-2020)
  • Table 58. France Seasickness Medicine, by Type USD Million (2015-2020)
  • Table 59. France Seasickness Medicine, by Route of Administration USD Million (2015-2020)
  • Table 60. France Seasickness Medicine, by Distribution Channel USD Million (2015-2020)
  • Table 61. Italy Seasickness Medicine, by Type USD Million (2015-2020)
  • Table 62. Italy Seasickness Medicine, by Route of Administration USD Million (2015-2020)
  • Table 63. Italy Seasickness Medicine, by Distribution Channel USD Million (2015-2020)
  • Table 64. United Kingdom Seasickness Medicine, by Type USD Million (2015-2020)
  • Table 65. United Kingdom Seasickness Medicine, by Route of Administration USD Million (2015-2020)
  • Table 66. United Kingdom Seasickness Medicine, by Distribution Channel USD Million (2015-2020)
  • Table 67. Netherlands Seasickness Medicine, by Type USD Million (2015-2020)
  • Table 68. Netherlands Seasickness Medicine, by Route of Administration USD Million (2015-2020)
  • Table 69. Netherlands Seasickness Medicine, by Distribution Channel USD Million (2015-2020)
  • Table 70. Rest of Europe Seasickness Medicine, by Type USD Million (2015-2020)
  • Table 71. Rest of Europe Seasickness Medicine, by Route of Administration USD Million (2015-2020)
  • Table 72. Rest of Europe Seasickness Medicine, by Distribution Channel USD Million (2015-2020)
  • Table 73. MEA Seasickness Medicine, by Country USD Million (2015-2020)
  • Table 74. MEA Seasickness Medicine, by Type USD Million (2015-2020)
  • Table 75. MEA Seasickness Medicine, by Route of Administration USD Million (2015-2020)
  • Table 76. MEA Seasickness Medicine, by Distribution Channel USD Million (2015-2020)
  • Table 77. Middle East Seasickness Medicine, by Type USD Million (2015-2020)
  • Table 78. Middle East Seasickness Medicine, by Route of Administration USD Million (2015-2020)
  • Table 79. Middle East Seasickness Medicine, by Distribution Channel USD Million (2015-2020)
  • Table 80. Africa Seasickness Medicine, by Type USD Million (2015-2020)
  • Table 81. Africa Seasickness Medicine, by Route of Administration USD Million (2015-2020)
  • Table 82. Africa Seasickness Medicine, by Distribution Channel USD Million (2015-2020)
  • Table 83. North America Seasickness Medicine, by Country USD Million (2015-2020)
  • Table 84. North America Seasickness Medicine, by Type USD Million (2015-2020)
  • Table 85. North America Seasickness Medicine, by Route of Administration USD Million (2015-2020)
  • Table 86. North America Seasickness Medicine, by Distribution Channel USD Million (2015-2020)
  • Table 87. United States Seasickness Medicine, by Type USD Million (2015-2020)
  • Table 88. United States Seasickness Medicine, by Route of Administration USD Million (2015-2020)
  • Table 89. United States Seasickness Medicine, by Distribution Channel USD Million (2015-2020)
  • Table 90. Canada Seasickness Medicine, by Type USD Million (2015-2020)
  • Table 91. Canada Seasickness Medicine, by Route of Administration USD Million (2015-2020)
  • Table 92. Canada Seasickness Medicine, by Distribution Channel USD Million (2015-2020)
  • Table 93. Mexico Seasickness Medicine, by Type USD Million (2015-2020)
  • Table 94. Mexico Seasickness Medicine, by Route of Administration USD Million (2015-2020)
  • Table 95. Mexico Seasickness Medicine, by Distribution Channel USD Million (2015-2020)
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Seasickness Medicine: by Type(USD Million)
  • Table 106. Seasickness Medicine Anticholinergic , by Region USD Million (2021-2026)
  • Table 107. Seasickness Medicine Antihistamines , by Region USD Million (2021-2026)
  • Table 108. Seasickness Medicine: by Route of Administration(USD Million)
  • Table 109. Seasickness Medicine Oral , by Region USD Million (2021-2026)
  • Table 110. Seasickness Medicine Transdermal , by Region USD Million (2021-2026)
  • Table 111. Seasickness Medicine Parenteral , by Region USD Million (2021-2026)
  • Table 112. Seasickness Medicine Other , by Region USD Million (2021-2026)
  • Table 113. Seasickness Medicine: by Distribution Channel(USD Million)
  • Table 114. Seasickness Medicine Retail Pharmacies , by Region USD Million (2021-2026)
  • Table 115. Seasickness Medicine Online Pharmacies , by Region USD Million (2021-2026)
  • Table 116. Seasickness Medicine Others , by Region USD Million (2021-2026)
  • Table 117. South America Seasickness Medicine, by Country USD Million (2021-2026)
  • Table 118. South America Seasickness Medicine, by Type USD Million (2021-2026)
  • Table 119. South America Seasickness Medicine, by Route of Administration USD Million (2021-2026)
  • Table 120. South America Seasickness Medicine, by Distribution Channel USD Million (2021-2026)
  • Table 121. Brazil Seasickness Medicine, by Type USD Million (2021-2026)
  • Table 122. Brazil Seasickness Medicine, by Route of Administration USD Million (2021-2026)
  • Table 123. Brazil Seasickness Medicine, by Distribution Channel USD Million (2021-2026)
  • Table 124. Argentina Seasickness Medicine, by Type USD Million (2021-2026)
  • Table 125. Argentina Seasickness Medicine, by Route of Administration USD Million (2021-2026)
  • Table 126. Argentina Seasickness Medicine, by Distribution Channel USD Million (2021-2026)
  • Table 127. Rest of South America Seasickness Medicine, by Type USD Million (2021-2026)
  • Table 128. Rest of South America Seasickness Medicine, by Route of Administration USD Million (2021-2026)
  • Table 129. Rest of South America Seasickness Medicine, by Distribution Channel USD Million (2021-2026)
  • Table 130. Asia Pacific Seasickness Medicine, by Country USD Million (2021-2026)
  • Table 131. Asia Pacific Seasickness Medicine, by Type USD Million (2021-2026)
  • Table 132. Asia Pacific Seasickness Medicine, by Route of Administration USD Million (2021-2026)
  • Table 133. Asia Pacific Seasickness Medicine, by Distribution Channel USD Million (2021-2026)
  • Table 134. China Seasickness Medicine, by Type USD Million (2021-2026)
  • Table 135. China Seasickness Medicine, by Route of Administration USD Million (2021-2026)
  • Table 136. China Seasickness Medicine, by Distribution Channel USD Million (2021-2026)
  • Table 137. Japan Seasickness Medicine, by Type USD Million (2021-2026)
  • Table 138. Japan Seasickness Medicine, by Route of Administration USD Million (2021-2026)
  • Table 139. Japan Seasickness Medicine, by Distribution Channel USD Million (2021-2026)
  • Table 140. India Seasickness Medicine, by Type USD Million (2021-2026)
  • Table 141. India Seasickness Medicine, by Route of Administration USD Million (2021-2026)
  • Table 142. India Seasickness Medicine, by Distribution Channel USD Million (2021-2026)
  • Table 143. South Korea Seasickness Medicine, by Type USD Million (2021-2026)
  • Table 144. South Korea Seasickness Medicine, by Route of Administration USD Million (2021-2026)
  • Table 145. South Korea Seasickness Medicine, by Distribution Channel USD Million (2021-2026)
  • Table 146. Taiwan Seasickness Medicine, by Type USD Million (2021-2026)
  • Table 147. Taiwan Seasickness Medicine, by Route of Administration USD Million (2021-2026)
  • Table 148. Taiwan Seasickness Medicine, by Distribution Channel USD Million (2021-2026)
  • Table 149. Australia Seasickness Medicine, by Type USD Million (2021-2026)
  • Table 150. Australia Seasickness Medicine, by Route of Administration USD Million (2021-2026)
  • Table 151. Australia Seasickness Medicine, by Distribution Channel USD Million (2021-2026)
  • Table 152. Rest of Asia-Pacific Seasickness Medicine, by Type USD Million (2021-2026)
  • Table 153. Rest of Asia-Pacific Seasickness Medicine, by Route of Administration USD Million (2021-2026)
  • Table 154. Rest of Asia-Pacific Seasickness Medicine, by Distribution Channel USD Million (2021-2026)
  • Table 155. Europe Seasickness Medicine, by Country USD Million (2021-2026)
  • Table 156. Europe Seasickness Medicine, by Type USD Million (2021-2026)
  • Table 157. Europe Seasickness Medicine, by Route of Administration USD Million (2021-2026)
  • Table 158. Europe Seasickness Medicine, by Distribution Channel USD Million (2021-2026)
  • Table 159. Germany Seasickness Medicine, by Type USD Million (2021-2026)
  • Table 160. Germany Seasickness Medicine, by Route of Administration USD Million (2021-2026)
  • Table 161. Germany Seasickness Medicine, by Distribution Channel USD Million (2021-2026)
  • Table 162. France Seasickness Medicine, by Type USD Million (2021-2026)
  • Table 163. France Seasickness Medicine, by Route of Administration USD Million (2021-2026)
  • Table 164. France Seasickness Medicine, by Distribution Channel USD Million (2021-2026)
  • Table 165. Italy Seasickness Medicine, by Type USD Million (2021-2026)
  • Table 166. Italy Seasickness Medicine, by Route of Administration USD Million (2021-2026)
  • Table 167. Italy Seasickness Medicine, by Distribution Channel USD Million (2021-2026)
  • Table 168. United Kingdom Seasickness Medicine, by Type USD Million (2021-2026)
  • Table 169. United Kingdom Seasickness Medicine, by Route of Administration USD Million (2021-2026)
  • Table 170. United Kingdom Seasickness Medicine, by Distribution Channel USD Million (2021-2026)
  • Table 171. Netherlands Seasickness Medicine, by Type USD Million (2021-2026)
  • Table 172. Netherlands Seasickness Medicine, by Route of Administration USD Million (2021-2026)
  • Table 173. Netherlands Seasickness Medicine, by Distribution Channel USD Million (2021-2026)
  • Table 174. Rest of Europe Seasickness Medicine, by Type USD Million (2021-2026)
  • Table 175. Rest of Europe Seasickness Medicine, by Route of Administration USD Million (2021-2026)
  • Table 176. Rest of Europe Seasickness Medicine, by Distribution Channel USD Million (2021-2026)
  • Table 177. MEA Seasickness Medicine, by Country USD Million (2021-2026)
  • Table 178. MEA Seasickness Medicine, by Type USD Million (2021-2026)
  • Table 179. MEA Seasickness Medicine, by Route of Administration USD Million (2021-2026)
  • Table 180. MEA Seasickness Medicine, by Distribution Channel USD Million (2021-2026)
  • Table 181. Middle East Seasickness Medicine, by Type USD Million (2021-2026)
  • Table 182. Middle East Seasickness Medicine, by Route of Administration USD Million (2021-2026)
  • Table 183. Middle East Seasickness Medicine, by Distribution Channel USD Million (2021-2026)
  • Table 184. Africa Seasickness Medicine, by Type USD Million (2021-2026)
  • Table 185. Africa Seasickness Medicine, by Route of Administration USD Million (2021-2026)
  • Table 186. Africa Seasickness Medicine, by Distribution Channel USD Million (2021-2026)
  • Table 187. North America Seasickness Medicine, by Country USD Million (2021-2026)
  • Table 188. North America Seasickness Medicine, by Type USD Million (2021-2026)
  • Table 189. North America Seasickness Medicine, by Route of Administration USD Million (2021-2026)
  • Table 190. North America Seasickness Medicine, by Distribution Channel USD Million (2021-2026)
  • Table 191. United States Seasickness Medicine, by Type USD Million (2021-2026)
  • Table 192. United States Seasickness Medicine, by Route of Administration USD Million (2021-2026)
  • Table 193. United States Seasickness Medicine, by Distribution Channel USD Million (2021-2026)
  • Table 194. Canada Seasickness Medicine, by Type USD Million (2021-2026)
  • Table 195. Canada Seasickness Medicine, by Route of Administration USD Million (2021-2026)
  • Table 196. Canada Seasickness Medicine, by Distribution Channel USD Million (2021-2026)
  • Table 197. Mexico Seasickness Medicine, by Type USD Million (2021-2026)
  • Table 198. Mexico Seasickness Medicine, by Route of Administration USD Million (2021-2026)
  • Table 199. Mexico Seasickness Medicine, by Distribution Channel USD Million (2021-2026)
  • Table 200. Research Programs/Design for This Report
  • Table 201. Key Data Information from Secondary Sources
  • Table 202. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Seasickness Medicine: by Type USD Million (2015-2020)
  • Figure 5. Global Seasickness Medicine: by Route of Administration USD Million (2015-2020)
  • Figure 6. Global Seasickness Medicine: by Distribution Channel USD Million (2015-2020)
  • Figure 7. South America Seasickness Medicine Share (%), by Country
  • Figure 8. Asia Pacific Seasickness Medicine Share (%), by Country
  • Figure 9. Europe Seasickness Medicine Share (%), by Country
  • Figure 10. MEA Seasickness Medicine Share (%), by Country
  • Figure 11. North America Seasickness Medicine Share (%), by Country
  • Figure 12. Global Seasickness Medicine share by Players 2020 (%)
  • Figure 13. Global Seasickness Medicine share by Players (Top 3) 2020(%)
  • Figure 14. Global Seasickness Medicine share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. GlaxoSmithKline plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 17. GlaxoSmithKline plc (United Kingdom) Revenue: by Geography 2020
  • Figure 18. Perrigo Company plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 19. Perrigo Company plc (Ireland) Revenue: by Geography 2020
  • Figure 20. Prestige Brands (United States) Revenue, Net Income and Gross profit
  • Figure 21. Prestige Brands (United States) Revenue: by Geography 2020
  • Figure 22. WellSpring Pharmaceutical Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 23. WellSpring Pharmaceutical Corporation (United States) Revenue: by Geography 2020
  • Figure 24. Caleb Pharmaceuticals (Taiwan) Revenue, Net Income and Gross profit
  • Figure 25. Caleb Pharmaceuticals (Taiwan) Revenue: by Geography 2020
  • Figure 26. Myungmoon Pharm Co. (South Korea) Revenue, Net Income and Gross profit
  • Figure 27. Myungmoon Pharm Co. (South Korea) Revenue: by Geography 2020
  • Figure 28. Baxter International (United States) Revenue, Net Income and Gross profit
  • Figure 29. Baxter International (United States) Revenue: by Geography 2020
  • Figure 30. Reliefband Technologies LLC. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Reliefband Technologies LLC. (United States) Revenue: by Geography 2020
  • Figure 32. CVS Health (United States) Revenue, Net Income and Gross profit
  • Figure 33. CVS Health (United States) Revenue: by Geography 2020
  • Figure 34. Global Seasickness Medicine: by Type USD Million (2021-2026)
  • Figure 35. Global Seasickness Medicine: by Route of Administration USD Million (2021-2026)
  • Figure 36. Global Seasickness Medicine: by Distribution Channel USD Million (2021-2026)
  • Figure 37. South America Seasickness Medicine Share (%), by Country
  • Figure 38. Asia Pacific Seasickness Medicine Share (%), by Country
  • Figure 39. Europe Seasickness Medicine Share (%), by Country
  • Figure 40. MEA Seasickness Medicine Share (%), by Country
  • Figure 41. North America Seasickness Medicine Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • GlaxoSmithKline plc (United Kingdom)
  • Perrigo Company plc (Ireland)
  • Prestige Brands (United States)
  • WellSpring Pharmaceutical Corporation (United States)
  • Caleb Pharmaceuticals (Taiwan)
  • Myungmoon Pharm Co. (South Korea)
  • Baxter International (United States)
  • Reliefband Technologies LLC. (United States)
  • CVS Health (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation